98 related articles for article (PubMed ID: 31376064)
21. Long non-coding RNA OIP5-AS1 suppresses microRNA-92a to augment proliferation and metastasis of ovarian cancer cells through upregulating ITGA6.
Wang Y; Li L; Zhang X; Zhao X
J Ovarian Res; 2022 Feb; 15(1):25. PubMed ID: 35168644
[TBL] [Abstract][Full Text] [Related]
22. Downregulated miR-17, miR-29c, miR-92a and miR-214 may be related to BCL11B overexpression in T cell acute lymphoblastic leukemia.
He Z; Liao Z; Chen S; Li B; Yu Z; Luo G; Yang L; Zeng C; Li Y
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e259-e265. PubMed ID: 29749698
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-92a Promotes Cell Proliferation in Cervical Cancer via Inhibiting p21 Expression and Promoting Cell Cycle Progression.
Su Z; Yang H; Zhao M; Wang Y; Deng G; Chen R
Oncol Res; 2017 Jan; 25(1):137-145. PubMed ID: 28081742
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN.
Ren P; Gong F; Zhang Y; Jiang J; Zhang H
Tumour Biol; 2016 Mar; 37(3):3215-25. PubMed ID: 26432332
[TBL] [Abstract][Full Text] [Related]
25. Inducing cell proliferative prevention in human acute promyelocytic leukemia by miR-182 inhibition through modulation of CASP9 expression.
Fasihi-Ramandi M; Moridnia A; Najafi A; Sharifi M
Biomed Pharmacother; 2017 May; 89():1152-1158. PubMed ID: 28298075
[TBL] [Abstract][Full Text] [Related]
26. MiR-92a inhibits proliferation and promotes apoptosis of OSCC cells through Wnt/β-catenin signaling pathway.
Zheng TL; Cen K
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4803-4809. PubMed ID: 32432743
[TBL] [Abstract][Full Text] [Related]
27. Retraction Note: Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.
Su K; Zhang T; Wang Y; Hao G
World J Surg Oncol; 2019 Jul; 17(1):119. PubMed ID: 31291954
[TBL] [Abstract][Full Text] [Related]
28. Regulation of miR-92a on vascular endothelial aging via mediating Nrf2-KEAP1-ARE signal pathway.
Liu H; Wu HY; Wang WY; Zhao ZL; Liu XY; Wang LY
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2734-2742. PubMed ID: 28678311
[TBL] [Abstract][Full Text] [Related]
29. Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells.
Hu S; Liu L; Chang EB; Wang JY; Raufman JP
Mol Cancer; 2015 Oct; 14():180. PubMed ID: 26463716
[TBL] [Abstract][Full Text] [Related]
30. Retraction Note: Mir-655 up-regulation suppresses cell invasion by targeting pituitary tumor-transforming gene-1 in esophageal squamous cell carcinoma.
Wang Y; Zang W; Du Y; Ma Y; Li M; Li P; Chen X; Wang T; Dong Z; Zhao G
J Transl Med; 2020 Feb; 18(1):89. PubMed ID: 32066458
[TBL] [Abstract][Full Text] [Related]
31. MiR-92a regulates oral squamous cell carcinoma (OSCC) cell growth by targeting FOXP1 expression.
Guo J; Wen N; Yang S; Guan X; Cang S
Biomed Pharmacother; 2018 Aug; 104():77-86. PubMed ID: 29772443
[TBL] [Abstract][Full Text] [Related]
32. The relationship between miR-17-5p, miR-92a, and let-7b expression with non-small cell lung cancer targeted drug resistance.
Gong J; He L; Ma J; Zhang J; Wang L; Wang J
J BUON; 2017; 22(2):454-461. PubMed ID: 28534369
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-92a-3p Enhances Cisplatin Resistance by Regulating Krüppel-Like Factor 4-Mediated Cell Apoptosis and Epithelial-to-Mesenchymal Transition in Cervical Cancer.
Yang J; Hai J; Dong X; Zhang M; Duan S
Front Pharmacol; 2021; 12():783213. PubMed ID: 35095494
[TBL] [Abstract][Full Text] [Related]
34. Histone deacetylase 9 inhibition upregulates microRNA-92a to repress the progression of intracranial aneurysm via silencing Bcl-2-like protein 11.
Cai Y; Huang D; Ma W; Wang M; Qin Q; Jiang Z; Liu M
J Drug Target; 2021 Aug; 29(7):761-770. PubMed ID: 33480300
[TBL] [Abstract][Full Text] [Related]
35. MiR-92a inhibits porcine ovarian granulosa cell apoptosis by targeting Smad7 gene.
Liu J; Yao W; Yao Y; Du X; Zhou J; Ma B; Liu H; Li Q; Pan Z
FEBS Lett; 2014 Nov; 588(23):4497-503. PubMed ID: 25448599
[TBL] [Abstract][Full Text] [Related]
36. Retraction note: The prevalence of obstructive sleep apnea in patients with difficult-to-treat asthma.
Asian Pac J Allergy Immunol; 2015 Dec; 33(4):349. PubMed ID: 26708400
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-92a inhibition attenuates hypoxia/reoxygenation-induced myocardiocyte apoptosis by targeting Smad7.
Zhang B; Zhou M; Li C; Zhou J; Li H; Zhu D; Wang Z; Chen A; Zhao Q
PLoS One; 2014; 9(6):e100298. PubMed ID: 24941323
[TBL] [Abstract][Full Text] [Related]
38. [Retracted] PAX6, a novel target of miR-335, inhibits cell proliferation and invasion in glioma cells.
Cheng Q; Cao H; Chen Z; Ma Z; Wan X; Peng R; Jiang B
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278488
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-92a Targets SERTAD3 and Regulates the Growth, Invasion, and Migration of Prostate Cancer Cells via the P53 Pathway.
Zhang S; Yu J; Sun BF; Hou GZ; Yu ZJ; Luo H
Onco Targets Ther; 2020; 13():5495-5514. PubMed ID: 32606766
[TBL] [Abstract][Full Text] [Related]
40. MiR-92a inhibits fibroblast-like synoviocyte proliferation and migration in rheumatoid arthritis by targeting AKT2.
Yu FY; Xie CQ; Jiang CL; Sun JT; Feng HC; Li C; Huang XW
J Biosci; 2018 Dec; 43(5):911-919. PubMed ID: 30541951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
